3-Chloro-4-fluorobenzoic acid | CAS:403-16-7

We serve 3-Chloro-4-fluorobenzoic acid CAS:403-16-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Chloro-4-fluorobenzoic acid

Chemical Name:3-Chloro-4-fluorobenzoic acid
CAS.NO:403-16-7
Synonyms:3-Chloro-4-fluorobenzoic acid
4-FLUORO-3-CHLOROBENZOIC ACID
Molecular Formula:C7H4ClFO2
Molecular Weight:174.55700
 
Physical and Chemical Properties:
Density:1.477
Melting point:133-136ºC
 
Specification:
Appearance:White solid
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 3-Chloro-4-fluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-FLUORO-3-CHLOROBENZOIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Chloro-4-fluorobenzoic acid Use and application,4-FLUORO-3-CHLOROBENZOIC ACID technical grade,usp/ep/jp grade.


Related News: The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.N-(3-trimethoxysilylpropyl)aniline manufacturer The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.ethyl (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate supplier Slow business: Due to fear — and travel warnings — fewer people want to travel to China.3-Chlorobenzoyl chloride vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.